Overview
Olfactory neuroendocrine carcinoma (ONC) is a rare malignancy that arises from the olfactory neuroepithelial cells lining the olfactory cleft. While ONC is uncommon, understanding its epidemiology, clinical presentation, and diagnostic approach is crucial for accurate diagnosis and management. This guideline synthesizes current evidence, primarily from a study involving 75 pre-septorhinoplasty patients, to provide clinicians with a comprehensive overview of the condition. The study highlights the prevalence of structural abnormalities within the olfactory cleft, emphasizing the importance of thorough preoperative assessment to differentiate benign findings from potentially more serious pathologies.
Epidemiology
The epidemiology of structural abnormalities within the olfactory cleft, as highlighted by a study involving 75 pre-septorhinoplasty patients, provides valuable insights into the frequency of these conditions [PMID:38206402]. In this cohort, partial olfactory cleft stenosis was observed in 58.7% of patients, while partial obstruction was noted in 46.7%. These findings suggest that structural anomalies within the olfactory cleft are relatively common, particularly in the context of planned septorhinoplasty procedures. The high prevalence of these abnormalities underscores the need for meticulous preoperative evaluation to ensure accurate diagnosis and appropriate management planning. Clinically, these structural issues often present without overt symptoms, making routine imaging and clinical assessment essential for comprehensive patient care.
Clinical Presentation
The clinical presentation of patients with varying degrees of olfactory cleft (OC) stenosis and obstruction, as detailed in the aforementioned study, reveals intriguing patterns that are crucial for clinical interpretation [PMID:38206402]. Notably, there was no significant difference in olfactory status—whether normosmic (normal sense of smell) or hyposmic (reduced sense of smell)—among patients with different severities of stenosis and obstruction. This observation implies that structural abnormalities within the olfactory cleft do not necessarily correlate with overt olfactory dysfunction in many cases. However, clinicians should remain vigilant as subtle changes in olfactory function might still be present and could be indicative of underlying pathology. In clinical practice, patients may present with vague symptoms such as nasal congestion or discomfort, but more specific olfactory complaints are less frequent unless the obstruction is severe. Therefore, a thorough history and physical examination, complemented by objective olfactory testing when feasible, are recommended to assess olfactory function accurately.
Diagnosis
Accurate diagnosis of olfactory cleft abnormalities hinges on a combination of clinical assessment and advanced imaging techniques, as evidenced by the radiologic evaluations conducted in the study [PMID:38206402]. Computed tomography (CT) scans played a pivotal role in identifying partial stenosis in 58.7% of patients and partial obstruction in 46.7%. These imaging modalities provide detailed anatomical information, crucial for preoperative planning and differentiating benign structural variations from more serious conditions. In clinical practice, CT scans are often the first-line imaging tool due to their availability and effectiveness in visualizing the bony and soft tissue structures of the nasal cavity. However, additional imaging such as magnetic resonance imaging (MRI) may be considered in complex cases to assess soft tissue involvement more comprehensively. Endoscopic examination can also offer valuable insights, particularly in assessing the patency of the olfactory cleft and identifying any associated mucosal changes. Therefore, a multidisciplinary approach combining clinical judgment with advanced imaging techniques is essential for accurate diagnosis.
Differential Diagnosis
Differentiating between benign structural abnormalities and more serious underlying causes in cases of olfactory cleft obstruction requires careful clinical evaluation, as indicated by the study findings [PMID:38206402]. Among the 75 patients studied, only one individual exhibited complete OC obstruction, highlighting the rarity of such severe cases. This rarity underscores the importance of thorough investigation to rule out other potential causes of complete obstruction, such as neoplastic processes, chronic sinusitis, or traumatic injuries. Clinicians should consider a broad differential diagnosis that includes inflammatory conditions, infectious etiologies, and malignancies, particularly in patients presenting with complete obstruction. Diagnostic workup should include detailed imaging studies, histopathological analysis if tissue samples are available, and possibly olfactory function tests to assess the extent of functional impairment. Collaboration with otolaryngologists and neurologists may be necessary to ensure a comprehensive evaluation and appropriate management plan tailored to each patient's specific clinical scenario.
Management
The management of olfactory cleft abnormalities varies based on the severity and clinical significance of the findings, though specific therapeutic guidelines are limited by the current evidence base [PMID:38206402]. For patients with partial stenosis and obstruction, which are frequently benign findings, conservative management often suffices. This may include monitoring for any changes in symptoms or structural progression, alongside symptomatic relief measures such as nasal saline irrigation and decongestants. In cases where these abnormalities are identified preoperatively for septorhinoplasty, surgical planning must carefully consider the impact on olfactory function and overall nasal anatomy. For instances of complete obstruction, where the study suggests a need for heightened clinical scrutiny, a more aggressive approach might be warranted. This could involve detailed diagnostic workup to rule out malignancy or other serious pathologies, potentially leading to targeted interventions such as endoscopic sinus surgery or other reconstructive procedures. Multidisciplinary consultation, involving otolaryngologists, neurologists, and possibly oncologists, is crucial to tailor the management plan effectively, ensuring both functional preservation and addressing any underlying pathologies comprehensively.
Key Recommendations
Based on the evidence synthesized from the study involving 75 pre-septorhinoplasty patients, several key recommendations emerge for the clinical management of olfactory cleft abnormalities [PMID:38206402]:
These recommendations are informed by expert opinion and the clinical insights derived from the study, aiming to optimize patient care and outcomes in managing olfactory cleft abnormalities.
References
1 Imbs S, Deyrail B, Nguyen DT, Hossu G, Blum A, Gondim Teixeira PA et al.. Olfactory cleft stenosis and obstruction on paranasal sinus CT scan in pre-septo-rhinoplasty patients: normal variants or pathologic findings?. European radiology 2024. link
1 papers cited of 3 indexed.